Udemy Inc header image

Udemy Inc

UDMY

Equity

ISIN US9026851066 / Valor 114176816

NASDAQ (2024-09-18)
USD 7.94-1.24%

Udemy Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Udemy Inc. is a global online learning platform offering a wide range of courses taught by expert instructors, catering to both professional development and personal interests.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (13.06.2024):

Revenue Growth

Udemy Inc reported a significant increase in revenue for the fourth quarter of 2023, with total revenue rising 15% year-over-year to $189.5 million. This growth exceeded the high end of Udemy’s guidance for the quarter by approximately $3 million, despite a negative impact of 1 percentage point from changes in foreign exchange rates year-over-year.

Enterprise Segment Expansion

The Enterprise segment, or Udemy Business, saw a notable revenue increase of 27% year-over-year to $114.7 million in the fourth quarter of 2023. This includes a negative impact of 2 percentage points from changes in foreign exchange rates. Udemy Business's Annual Recurring Revenue (ARR) also grew by 25% year-over-year to $466.0 million.

Consumer Segment Stability

Udemy Inc's Consumer segment revenue remained stable year-over-year at $74.9 million in the fourth quarter of 2023, including a negligible impact of less than one percentage point from changes in foreign exchange rates. This stability highlights the consistent demand for Udemy’s consumer-oriented educational content.

Net Loss Improvement

Udemy Inc reported a net loss of $20.2 million in the fourth quarter of 2023, which is a significant improvement from a net loss of $52.2 million in the same quarter the previous year. This 61% reduction in net loss reflects Udemy's enhanced operational efficiency and cost management strategies.

Share Repurchase Program

Reflecting confidence in its financial health and future prospects, Udemy Inc's Board of Directors approved the company's first share repurchase program. Under this program, Udemy is authorized to repurchase up to $100 million of its common stock, which may be conducted through open market or privately negotiated transactions in accordance with SEC regulations.

Summarized from source with an LLMView Source

Key figures

-19.6%1Y
%3Y
%5Y

Performance

56.3%1Y
60.9%3Y
60.9%5Y

Volatility

Market cap

2214 M

Market cap (USD)

Daily traded volume (Shares)

358,707

Daily traded volume (Shares)

1 day high/low

8.195 / 7.92

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.35%USD 57.70
TransMedics Group Inc
TransMedics Group Inc TransMedics Group Inc Valor: 47361695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.08%USD 155.96
Embla Medical hf
Embla Medical hf Embla Medical hf Valor: 1060135
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.91%DKK 30.80
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc Xenon Pharmaceuticals Inc Valor: 25419823
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 40.09
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.89%USD 6.05
Galapagos NV
Galapagos NV Galapagos NV Valor: 3542077
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.92%USD 30.28
H. Lundbeck A/S
H. Lundbeck A/S H. Lundbeck A/S Valor: 119252584
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.64%DKK 39.05
Sareum Holdings PLC
Sareum Holdings PLC Sareum Holdings PLC Valor: 116566624
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.70%GBP 0.26
L'Oreal S.A.
L'Oreal S.A. L'Oreal S.A. Valor: 502805
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.69%EUR 365.80
EssilorLuxottica SA
EssilorLuxottica SA EssilorLuxottica SA Valor: 497537
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.34%EUR 204.80